Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study - Test2 - elhamkhani - TriplyDB

Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study

Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study

http://www.wikidata.org/entity/Q21558554

about

Monoclonal antibody therapy for neuromyelitis optica spectrum disorder: current and future.Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study.Neurological Disease in Lupus: Toward a Personalized Medicine Approach.Orthologous proteins of experimental de- and remyelination are differentially regulated in the CSF proteome of multiple sclerosis subtypes

P2860

Q38816869-15E976F7-284F-41AF-8C48-5BDCEADA5331 Q39785941-F1D53452-4796-4090-8754-D1BCCF9CD505 Q55267080-C13A6699-0C29-4D05-8703-1F090C889837 Q58774884-C8DBC777-06EB-4170-BFEC-B337AC2F59E5

P2860

Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study

http://www.wikidata.org/entity/Q21558554

description

2015 nî lūn-bûn

@nan

2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Change in autoantibody and cyt ...... hematosus: A preliminary study

@ast

Change in autoantibody and cyt ...... hematosus: A preliminary study

@en

Change in autoantibody and cyt ...... hematosus: A preliminary study

@en-gb

Change in autoantibody and cyt ...... hematosus: A preliminary study

@nl

type

label

Change in autoantibody and cyt ...... hematosus: A preliminary study

@ast

Change in autoantibody and cyt ...... hematosus: A preliminary study

@en

Change in autoantibody and cyt ...... hematosus: A preliminary study

@en-gb

Change in autoantibody and cyt ...... hematosus: A preliminary study

@nl

prefLabel

Change in autoantibody and cyt ...... hematosus: A preliminary study

@ast

Change in autoantibody and cyt ...... hematosus: A preliminary study

@en

Change in autoantibody and cyt ...... hematosus: A preliminary study

@en-gb

Change in autoantibody and cyt ...... hematosus: A preliminary study

@nl

P1433

Q21558554-3B514A25-9A33-43C4-B6BC-81F88A2150D7

P1476

Q21558554-C8D451A7-8A1C-428B-95A8-F03861AFD094

P2093

Q21558554-01D1115E-5469-4CF2-85E4-99E9B5CBEF2D

Q21558554-0F56CE40-3AB7-42D6-A73E-DAA9D22D30B2

Q21558554-1BC7056D-7E73-42ED-8A78-A73D9662CA01

Q21558554-65FBE48A-FE1A-4909-9AAE-A46B6429A6D0

Q21558554-84E848C8-2F3B-4844-BF75-A1B14C9CB014

Q21558554-B0743A77-DBBA-4971-9398-740D8102296B

Q21558554-B7EDD50F-6584-4F06-83F1-ADF2A879F9C1

Q21558554-BBCFF6F7-734A-4C6D-AD06-27EE94F903D3

Q21558554-BCE7DD3D-EA7A-4053-BDEE-63EFB4E533EF

Q21558554-CE541F09-9CF3-4CFE-9D02-6D651CC14800

P2860

Q21558554-030BB588-0368-4BA5-9664-79032492035B

Q21558554-07D21F57-7535-40D5-83C6-47FA6E63CD95

Q21558554-14135689-814C-4161-A1DA-FCED647CFFF4

Q21558554-1B360C04-D53B-403F-9129-2581FA432140

Q21558554-1E727D5C-B659-4DB2-A612-5120086A2C79

Q21558554-1EE2DFF3-7803-4CA6-92BB-B3D0E82AC41E

Q21558554-3680311E-F3C8-4EDD-B921-E9388C90C4C1

Q21558554-5A45BEB7-FA42-435F-9B20-21F8F4D17056

Q21558554-6E67367C-3436-4057-819D-4C2D65E02F6F

Q21558554-8FB25DE9-C949-46AA-B303-BFA0A123116B

P304

Q21558554-9141881F-229B-4163-A655-93497D76BFB7

P31

Q21558554-5E9CD90E-4AFE-4CD8-ACA8-20BB49BC870B

P356

Q21558554-B9C15BA1-3782-4401-9A02-E0BD32E957AC

P407

Q21558554-2E90E318-2B0B-479B-8ABB-10C1C5033F09

P433

Q21558554-2BFA131B-5DC3-42D2-AA0D-31BE9CE7DAC2

P478

Q21558554-ABC38B61-2346-400B-AB1E-E33AA56A01B8

P50

Q21558554-A5FD5AEB-70D0-4EA5-A302-FDDDA5F8DEF0

Q21558554-B1CE3A81-4447-44C6-A7FD-D5F7D60BE214

Q21558554-B60B4D5F-7CC7-40FE-95C0-6FC58CFEDECC

P577

Q21558554-9E2D9E09-BFE8-40B3-AF40-508EA5DAE2DF

P5875

Q21558554-34AC04A5-064E-44DD-A3C7-3B643500FFEA

P698

Q21558554-B358C8A0-7542-4E73-A543-69D36B15677D

P921

Q21558554-C4C8EBD6-6E11-4C88-BBD7-482E1349AFD9

P356

1352458515613165

P1433

Multiple Sclerosis Journal

P1476

Change in autoantibody and cyt ...... hematosus: A preliminary study

@en

P2093

Bernhard Hemmer

http://www.w3.org/2001/XMLSchema#string

Katalin T Kovacs

http://www.w3.org/2001/XMLSchema#string

Laszlo Czirjak

http://www.w3.org/2001/XMLSchema#string

Laszlo Rokusz

http://www.w3.org/2001/XMLSchema#string

Magdolna Simo

http://www.w3.org/2001/XMLSchema#string

Sudhakar Reddy Kalluri

http://www.w3.org/2001/XMLSchema#string

Tihamer Molnar

http://www.w3.org/2001/XMLSchema#string

Timea Berki

http://www.w3.org/2001/XMLSchema#string

Tomas Deierborg

http://www.w3.org/2001/XMLSchema#string

Tunde Csepany

http://www.w3.org/2001/XMLSchema#string

P2860

A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays.

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

Immunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica.

Experimental models of neuromyelitis optica.

Functional characterization of aquaporin-4 specific T cells: towards a model for neuromyelitis optica

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.

P304

1192-1201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1352458515613165

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Nicolas Alcaraz

Antonio Boza-Serrano

P577

2015-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283447863

http://www.w3.org/2001/XMLSchema#string

P698

26514978

http://www.w3.org/2001/XMLSchema#string

P921